Search
HEMLIBRA 105 MG / 0.7 ML, Solution pour injection sous-cutanée
Details
| --- | Description |
|---|---|
| Pack | Boite de 1 flacon |
| Strength (Dosage) | 105 MG / 0.7 ML |
| Laboratory | ROCHE S.A |
| Ingredients | Emicizumab |
| Therapeutic class | Hémostatique, anticorps monoclonal humanisé modifié de type IgG4 |
| ATC code | B02BX06 |
| PPH | $5,543.10 |
| PPV | $5,653.10 |
| Refundable | No |
| Refund base | $0.00 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Hemlibra est indiqué en prophylaxie des épisodes hémorragiques chez les patients atteints d'hémophilie A (déficit congénital en facteur VIII) avec inhibiteurs anti-facteur VIII, chez les patients atteints d'hémophilie A sévère (déficit congénital en facteur VIII, FVIII <1%) sans inhibiteur anti-facteur VIII. Hemlibra peut être utilisé dans toutes les tranches d'âge. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem